Krishnamohan Neha (CIK 1866171) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-09). Recent activity: Buy ARQT (5,778 shares), Sell ARTV (3,490 shares), Buy ARQT (27,052 shares), Buy ARQT (12,220 shares), Sell ARQT (39,272 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 5,778 | $0 |
| 2025-11-17 | Artiva Biotherapeutics, Inc. (ARTV) | Chief Financial Officer | Sell | 3,490 | $11,342 |
| 2025-11-17 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 27,052 | $233,459 |
| 2025-11-17 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 12,220 | $91,772 |
| 2025-11-17 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Sell | 39,272 | $910,718 |
| 2025-11-17 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Sell | 1,232 | $28,792 |
| 2025-08-18 | Artiva Biotherapeutics, Inc. (ARTV) | Chief Financial Officer | Sell | 1,341 | $2,856 |
| 2025-08-18 | Artiva Biotherapeutics, Inc. (ARTV) | Chief Financial Officer | Sell | 5,813 | $15,986 |
| 2025-06-16 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 7,609 | $0 |
| 2025-02-28 | Artiva Biotherapeutics, Inc. (ARTV) | Chief Financial Officer | Buy | 60,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-09